Product

AMG 714

2 clinical trials

2 indications

Indication
Celiac Disease
Indication
Vitiligo
Clinical trial
AMG714 Expanded Access Program
Status:
Clinical trial
Evaluation of AMG 714 for Vitiligo: A Phase 2a Randomized Double Blind Placebo Controlled Trial (ITN086AI)
Status: Active (not recruiting), Estimated PCD: 2024-11-01